Latest News
GE HealthCare's Photonova Spectra gains FDA clearance
23 March 2026 - Healthcare solutions provider GE HealthCare (Nasdaq: GEHC) announced on Monday that it has received 510(k) clearance from the U.S. Food and Drug Administration for Photonova Spectra, its next-generation photon-counting CT system. The ...
HUTCHMED launches Phase III trial of HMPL-760 for DLBCL in China
23 March 2026 - Biopharmaceutical company HUTCHMED (China) Limited (Nasdaq: HCM) (AIM: HCM) (HKEX: 13) announced on Monday that it has initiated a registrational Phase III clinical trial of HMPL-760 in combination with R-GemOx in patients with relaps...
Pfizer and Valneva report strong Phase 3 results for Lyme disease vaccine candidate
23 March 2026 - US biopharmaceutical company Pfizer Inc (NYSE:PFE) and French vaccine company Valneva SE (Nasdaq:VALN) (Euronext Paris:VLA) on Monday reported positive topline results from the Phase 3 VALOR trial of their Lyme disease vaccine candida...
Futura Medical reports positive home user test results for Eroxon and Intense variant
23 March 2026 - Consumer healthcare company Futura Medical plc (AIM: FUM) reported on Monday that it has recorded positive results from a Home User Test evaluating its marketed Eroxon product alongside a prototype formulation, Eroxon Intense, reinfor...
GSK secures Japan Orphan Drug status for lung cancer ADC
23 March 2026 - Pharmaceutical company GSK plc (LSE: GSK) (NYSE: GSK) declared on Monday that it has received Orphan Drug Designation in Japan for its investigational antibody-drug conjugate, risvutatug rezetecan, for the treatment of small-cell lung...